Albemarle director receives 325-share stock grant

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation director Michelle T. Collins received a grant of 325 shares of common stock as part of non-employee director stock compensation. The award was granted under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors and carries a grant price of $0.00 per share.

These shares are scheduled to vest on July 1, 2026. After this grant, Collins directly holds 325 shares of Albemarle common stock, reflecting her current equity-based compensation as a newly appointed director within the compensation year.

Insider Trade Summary

Grant/Award: 325 shares

Grant/Award 1 txn

Insider Collins Michelle T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	325	$0.00	$0.00

Holdings After Transaction: Common Stock — 325 shares (Direct)

Footnotes (1)

1. F1. Shares represent a pro rata grant of an annual installment of non-employee director stock compensation to those directors who become directors after the first day of the Compensation Year pursuant to the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors. Shares to vest on July 1, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Albemarle (ALB) director Michelle T. Collins report in this Form 4?

Michelle T. Collins reported receiving a grant of 325 shares of Albemarle common stock. The award is part of non-employee director stock compensation and was granted at $0.00 per share, increasing her direct holdings to 325 shares.

Why did Michelle T. Collins receive 325 Albemarle (ALB) shares?

The 325-share grant represents a pro rata annual installment of non-employee director stock compensation. It applies to directors who join after the first day of the compensation year under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for non-employee directors.

When do the granted Albemarle (ALB) shares to Michelle T. Collins vest?

The 325 granted shares to Michelle T. Collins are scheduled to vest on July 1, 2026. Vesting means she fully earns the shares on that date, subject to the terms of Albemarle’s director compensation plan.

How many Albemarle (ALB) shares does Michelle T. Collins own after this transaction?

Following the stock award, Michelle T. Collins directly owns 325 shares of Albemarle common stock. This total reflects her holdings after receiving the non-employee director stock grant reported in the Form 4 filing.

Was cash paid for the Albemarle (ALB) shares granted to director Michelle T. Collins?

No cash was paid for this award; the transaction price per share was $0.00. The 325 shares were granted as equity compensation to Michelle T. Collins in her role as a non-employee director of Albemarle.

What Albemarle (ALB) plan governs Michelle T. Collins’ stock grant?

The grant was made under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors. This plan governs stock-based compensation, including the 325-share pro rata annual installment granted to Collins.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 05:12 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collins Michelle T

(Last) (First) (Middle)

4250 CONGRESS ST.

SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		325(1)	A	$0	325	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent a pro rata grant of an annual installment of non-employee director stock compensation to those directors who become directors after the first day of the Compensation Year pursuant to the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors. Shares to vest on July 1, 2026.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.